SOTTOTETTI, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 1.359
AS - Asia 835
EU - Europa 825
SA - Sud America 116
AF - Africa 40
Totale 3.175
Nazione #
US - Stati Uniti d'America 1.329
CN - Cina 262
SG - Singapore 240
IE - Irlanda 193
IT - Italia 135
RU - Federazione Russa 111
HK - Hong Kong 103
DE - Germania 97
VN - Vietnam 97
FI - Finlandia 86
BR - Brasile 82
FR - Francia 49
GB - Regno Unito 33
UA - Ucraina 32
ZA - Sudafrica 31
JP - Giappone 26
SE - Svezia 23
IN - India 22
BD - Bangladesh 19
CA - Canada 18
NL - Olanda 16
IQ - Iraq 12
PL - Polonia 11
TR - Turchia 10
AR - Argentina 9
CO - Colombia 9
MX - Messico 9
ES - Italia 8
MY - Malesia 6
AT - Austria 5
ID - Indonesia 5
PT - Portogallo 5
AL - Albania 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
CL - Cile 3
EC - Ecuador 3
KE - Kenya 3
PH - Filippine 3
AM - Armenia 2
BH - Bahrain 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LT - Lituania 2
MU - Mauritius 2
NP - Nepal 2
PE - Perù 2
PK - Pakistan 2
RS - Serbia 2
SA - Arabia Saudita 2
UY - Uruguay 2
UZ - Uzbekistan 2
AD - Andorra 1
AO - Angola 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
CM - Camerun 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
GE - Georgia 1
HR - Croazia 1
IL - Israele 1
IM - Isola di Man 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KR - Corea 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
NO - Norvegia 1
PY - Paraguay 1
TH - Thailandia 1
Totale 3.175
Città #
Dublin 193
Chandler 180
San Jose 167
Ashburn 124
Singapore 117
Hong Kong 101
Beijing 70
Dallas 69
New York 61
Helsinki 60
Los Angeles 45
Boardman 42
Munich 39
Ho Chi Minh City 38
Milan 36
Jacksonville 34
Lauterbourg 34
Princeton 30
Johannesburg 28
Nanjing 28
Lawrence 27
Shanghai 26
Tokyo 24
Medford 23
Council Bluffs 22
Hanoi 18
Moscow 18
São Paulo 18
Buffalo 15
Wilmington 15
Turku 14
Pavia 13
Boston 12
Warsaw 11
Brooklyn 10
Chicago 10
Nanchang 9
Santa Clara 9
Atlanta 8
Chennai 8
Denver 8
Redondo Beach 8
The Dalles 8
Hebei 7
Montreal 7
Norwalk 7
Novate Milanese 7
Amsterdam 6
Baghdad 6
Frankfurt am Main 6
London 6
Manchester 6
Orem 6
Shenyang 6
Changsha 5
Elk Grove Village 5
Mumbai 5
Naples 5
Nuremberg 5
Paris 5
Seattle 5
Toronto 5
Falkenstein 4
Guangzhou 4
Haiphong 4
Hangzhou 4
Houston 4
Medellín 4
Mexico City 4
Phoenix 4
Poplar 4
Pune 4
San Francisco 4
Stockholm 4
Tirana 4
Verona 4
Augusta 3
Biên Hòa 3
Brussels 3
Buenos Aires 3
Bến Tre 3
Can Tho 3
Cinisello Balsamo 3
Columbus 3
Da Nang 3
Falls Church 3
Hải Dương 3
Kuala Lumpur 3
Mariglianella 3
Nairobi 3
Querétaro 3
Rome 3
Tianjin 3
Washington 3
Woodbridge 3
Amman 2
Ankara 2
Ann Arbor 2
Beirut 2
Belo Horizonte 2
Totale 2.063
Nome #
Cluster familiare di mesotelioma da esposizione residenziale 156
Smoking Habit and Respiratory Function Predict Patients' Outcome after Surgery for Lung Cancer, Irrespective of Histotype and Disease Stage 130
OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma. 126
Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study 117
Role of androgen receptor expression in early stage ER+/PgR−/HER2– breast cancer 115
Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liver. 114
Eribulin across multiple lines of chemotherapy: A retrospective study on quality of life and efficacy in metastatic breast cancer patients 113
Patterns of treatment and outcome of palbociclib plus endocrine therapy in hormone receptor-positive/HER2 receptor-negative metastatic breast cancer: a real-world multicentre Italian study 108
Palbociclib in metastatic breast cancer: Current evidence and real-life data 103
Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study 102
Intravenous or oral vinorelbine plus capecitabine as first - line treatment in HER2- metastatic breast cancer: Joint Analysis of 2 Consecutive Prospective Phase II Trials. 99
Uncommon dihydropyrimidine dehydrogenase mutations and toxicity by fluoropyrimidines: A lethal case with a new variant 99
Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience 98
Nanoparticle albumin-bound paclitaxel (Nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: Prospective evaluation of activity, safety, and quality of life 98
Treatment of chronic hepatitis C in a patient affected by systemic sclerosis 98
Acute thrombocytopenia: An unusual complication occurring after drug-eluting microspheres transcatheter hepatic chemoembolization 97
Prognostic Value of 18 F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel 94
Raman analysis of microcalcifications in male breast cancer 94
Clinical and Biological Variables Influencing Outcome in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Anti-PD-1/PD-L1 Antibodies: A Prospective Multicentre Study 91
Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast cancer: joint analysis of 2 consecutive prospective phase II trials. 90
Italian real life experience with ibrutinib: Results of a large observational study on 77 relapsed/refractory mantle cell lymphoma 88
Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (nab -paclitaxel) in metastatic breast cancer: Which benefit for which patients? 87
Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for Unresectable Hepatic Tumors. 86
Impact of COVID-19 outbreak on cancer patient care and treatment: Data from an outpatient oncology clinic in Lombardy (Italy) 86
Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer 86
Patterns of treatment and outcome with 500-mg fulvestrant in postmenopausal women with hormone receptor-positive/HER2-negative metastatic breast cancer: a real-life multicenter Italian experience 85
Vitamin B12 status in hospitalised cancer patients: Prevalence and clinical implications of depletion and hypervitaminosis 79
Vinflunine in Advanced Transitional Cell Cancer of the Urothelial Tract: A Potential Option for Maintenance Therapy? A Case Series 76
Validation of an LC-MS/MS method for the determination of epirubicin in human serum of patients undergoing Drug Eluting Microsphere-Transarterial Chemoembolization (DEM-TACE) 76
Advanced salivary gland carcinoma expressing androgen receptor and HER2: targeted therapies first? 72
Which patients with metastatic breast cancer benefit from subsequent lines of treatment? An update for clinicians 66
Mental health and risk perception among Italian healthcare workers during the second month of the Covid-19 pandemic 61
Small bowel villous atrophy due to immune-checkpoint inhibitors: report of two cases and literature review 49
Exposure to Occupational Carcinogens and Non-Oncogene Addicted Phenotype in Lung Cancer: Results from a Real-Life Observational Study 45
Tackling the clinical complexity of breast cancer 35
Generative AI and medical oncologists: Be curious, but cautious! 1
A Prospective Randomized Trial Comparing Radioguided Occult Lesion Localization (ROLL) and Magnetic Seed Localization for the Localization of Nonpalpable Breast Lesions: Analysis of Surgical Outcomes, Patient’s Perception, and Costs 1
Totale 3.221
Categoria #
all - tutte 14.940
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.940


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/2022160 0 0 34 2 2 1 1 4 11 13 16 76
2022/2023517 66 60 5 35 36 42 1 24 224 1 11 12
2023/2024290 41 48 9 9 21 80 19 16 0 15 9 23
2024/2025655 21 43 36 26 17 51 13 63 166 25 60 134
2025/20261.415 108 75 109 174 224 56 247 89 151 89 61 32
Totale 3.221